Physician profile
Eric T Carniol
NPI 1255698387
$1,118.98
in general payments reported to CMS, 2019-2025
11 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.31 · 2020: $111 · 2021: $70.96 · 2022: $67.03 · 2023: $140 · 2024: $257 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746 · Consulting Fee: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.55 |
| Consulting Fee | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $619.60 | 2024-2025 | Daxxify |
| Allergan, INC. | $155.47 | 2020-2021 | |
| Aerin Medical INC. | $106.68 | 2022-2024 | |
| Medtronic, INC. | $75.00 | 2023 | Surgipro Ll, Merocel |
| Galderma Laboratories, L.P. | $49.31 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $27.12 | 2024 | |
| Stryker Corporation | $23.60 | 2021-2022 | |
| Olympus America INC. | $18.00 | 2022 | |
| Boston Scientific Corporation | $15.55 | 2024 | Ams 700 |
| Glaxosmithkline, LLC. | $14.81 | 2021 | |
| Optinose US, INC. | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Carniol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.